Cite

HARVARD Citation

    Lindegaard, H. et al. (2016). Doubling the single-dose infusion rate of tocilizumab in rheumatoid arthritis is safe and efficacious. Scandinavian journal of rheumatology. pp. 262-266. [Online]. 
  
Back to record